Both psoriasis and IBD involve dysregulation of the Th17 immune pathway and overexpression of cytokines such as IL-17 and IL-22, which sustain chronic inflammation in the skin and gastrointestinal tract [11,12]. The gene discussed is IL22; the disease is inflammatory bowel disease.